Steven Romick - First Pacific Advisors,
Holding/activity history for Enzon Pharmaceuticals Inc (EZ1)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2015 Q3 | 0 | 0.00 | Sell 100.00% | <0.01 | SEC | ||
| 2015 Q2 | 23,626 | <0.01 | $1.19 | $28,000 | SEC | ||
| 2015 Q1 | 23,626 | <0.01 | $1.06 | $25,000 | SEC | ||
| 2014 Q4 | 23,626 | <0.01 | Reduce 93.19% | <0.01 | $1.10 | $26,000 | SEC |
| 2014 Q3 | 347,035 | <0.01 | $1.08 | $375,000 | SEC | ||
| 2014 Q2 | 347,035 | <0.01 | $1.04 | $361,000 | SEC | ||
| 2014 Q1 | 347,035 | <0.01 | $1.03 | $357,000 | SEC | ||
| 2013 Q4 | 347,035 | <0.01 | Reduce 7.96% | <0.01 | $1.16 | $403,000 | SEC |
| 2013 Q3 | 377,035 | 0.01 | Reduce 0.73% | <0.01 | $1.68 | $633,000 | SEC |
| 2013 Q2 | 379,826 | 0.01 | $2.00 | $760,000 | SEC | ||
| 2013 Q1 | 379,826 | 0.02 | $3.80 | $1,443,000 | SEC | ||
| 2012 Q4 | 379,826 | 0.02 | $4.43 | $1,683,000 | SEC | ||
| 2012 Q3 | 379,826 | 0.03 | $6.96 | $2,644,000 | SEC | ||
| 2012 Q2 | 379,826 | 0.03 | Buy | 0.03 | $6.87 | $2,609,000 | SEC |